Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer20 Apr ETF APRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Buy
53,898
+9,207
+21% +$338K ﹤0.01% 1688
2026
Q1
$1.58M Sell
44,691
-3,590
-7% -$126K ﹤0.01% 1794
2025
Q4
$1.68M Sell
48,281
-1,708
-3% -$58.9K ﹤0.01% 1686
2025
Q3
$1.71M Buy
49,989
+91
+0.2% +$3.08K ﹤0.01% 1621
2025
Q2
$1.67M Buy
49,898
+7,346
+17% +$238K 0.01% 1562
2025
Q1
$1.36M Sell
42,552
-3,005
-7% -$99.2K ﹤0.01% 1622
2024
Q4
$1.5M Sell
45,557
-3,790
-8% -$124K 0.01% 1566
2024
Q3
$1.59M Sell
49,347
-13,163
-21% -$414K 0.01% 1529
2024
Q2
$1.95M Buy
62,510
+33,821
+118% +$1.03M 0.01% 1292
2024
Q1
$868K Sell
28,689
-1,155
-4% -$34.6K ﹤0.01% 1823
2023
Q4
$881K Sell
29,844
-1,783
-6% -$51K ﹤0.01% 1730
2023
Q3
$885K Sell
31,627
-1,368
-4% -$38.6K ﹤0.01% 1655
2023
Q2
$927K Sell
32,995
-1,152
-3% -$31.6K ﹤0.01% 1664
2023
Q1
$923K Sell
34,147
-5,858
-15% -$157K ﹤0.01% 1626
2022
Q4
$1.05M Sell
40,005
-2,726
-6% -$70.8K 0.01% 1484
2022
Q3
$1.07M Buy
42,731
+1,668
+4% +$43.3K 0.01% 1426
2022
Q2
$1.04M Buy
41,063
+22,294
+119% +$583K 0.01% 1453
2022
Q1
$511K Buy
+18,769
New +$505K ﹤0.01% 2084

Other funds holding APRW

Cambridge Investment Research Advisors's APRW Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its AllianzIM U.S. Equity Buffer20 Apr ETF (APRW) stake by 21% in Q2 2026, buying an estimated $338K and bringing the position to 53,898 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Cambridge Investment Research Advisors first reported a position in APRW in Q1 2022 and has held it in 18 quarters since. 68 funds tracked by Wall St. Rank hold APRW as of Q2 2026.

  • Cambridge Investment Research Advisors held 53,898 shares of AllianzIM U.S. Equity Buffer20 Apr ETF worth $2M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 9,207 AllianzIM U.S. Equity Buffer20 Apr ETF shares in Q2 2026, an estimated $338K.
  • AllianzIM U.S. Equity Buffer20 Apr ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1688 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer20 Apr ETF in Q1 2022 and has held it in 18 quarters since.
  • 68 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Apr ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.